Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification-Reference-Cited by-同舟云学术

Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification

Published:2022-12 Issue: Volume:86 Page:104373
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Zeng Peter Y.F.,Cecchini Matthew J.,Barrett John W.,Shammas-Toma Matthew,De Cecco Loris,Serafini Mara S.,Cavalieri Stefano^ORCID,Licitra Lisa,Hoebers Frank,Brakenhoff Ruud H.,Leemans C. René,Scheckenbach Kathrin,Poli Tito^ORCID,Wang Xiaowei,Liu Xinyi,Laxague Francisco,Prisman Eitan^ORCID,Poh Catherine,Bose Pinaki,Dort Joseph C.,Shaikh Mushfiq H.,Ryan Sarah E.B.,Dawson Alice,Khan Mohammed I.^ORCID,Howlett Christopher J.,Stecho William,Plantinga Paul,Daniela da Silva Sabrina,Hier Michael,Khan Halema,MacNeil Danielle,Mendez Adrian,Yoo John,Fung Kevin,Lang Pencilla,Winquist Eric,Palma David A.,Ziai Hedyeh,Amelio Antonio L.,Li Shawn S-C.,Boutros Paul C.,Mymryk Joe S.,Nichols Anthony C.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference79 articles.

1. Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: a systematic review of population-based studies;Menezes;Oral Oncol,2021

2. The changing therapeutic landscape of head and neck cancer;Cramer;Nat Rev Clin Oncol,2019

3. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

4. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma;Gillison;J Clin Oncol,2015

5. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer;Nichols;Clin Cancer Res,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-escalated radiation for human papillomavirus virus-related oropharyngeal cancer: Who, why, what, where, when, how, how much…and what next?;Radiotherapy and Oncology;2024-11

2. Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13+ CD4+ T cell activation in oropharyngeal cancer: implications for immunotherapy;Cancer Immunology, Immunotherapy;2024-08-06

3. Translational risk-adapted approaches to de-escalated radiation for human papillomavirus-positive oropharyngeal cancer: Past, present, and future;Oral Oncology;2024-07

4. Potential Transcript-Based Biomarkers Predicting Clinical Outcomes of HPV-Positive Head and Neck Squamous Cell Carcinoma Patients;Cells;2024-06-26

5. Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer;npj Precision Oncology;2024-05-23